Question: How do you turn aggressive breast, lung, and bladder cancer cells back into benign cells?
Answer: microRNAi’s. Continue reading
Question: How do you turn aggressive breast, lung, and bladder cancer cells back into benign cells?
Answer: microRNAi’s. Continue reading
Researchers examined large-scale genomic datasets and found that patients with higher levels of miR-182 had a better chance of surviving glioblastoma (GBM) longer. This prompted them to perform pre-clinical studies to elucidate the mechanism by which miR-182 acts. Continue reading